Delivery Order SPE2DR25D2104-SPE2DR26F3QSP
- Not listed
- The Defense Logistics Agency awarded a $1,735.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a common oral medication used to treat type 2 diabetes. The contract was competitively awarded with no set-aside designation and carries an ultimate completion date of April 23, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.55 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100, with an ultimate completion date of October 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's established role as a critical...
- The Defense Logistics Agency awarded a $1,960.24 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a medication commonly prescribed for type 2 diabetes management. This is a firm fixed-price, non-set-aside contract awarded on November 18, 2025, with completion scheduled for November 19, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,686.62 to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg on November 25, 2025, with completion scheduled for November 26, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Glimepiride is an oral antidiabetic medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,174.34 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count packaging) under a firm fixed-price contract. The award, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal healthcare vendor...
- The Defense Logistics Agency awarded a $1,784.23 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Glimepiride 4 mg, a generic medication commonly used in diabetes management. This firm fixed price, competitively awarded delivery order was finalized on August 11, 2025, with an ultimate completion date of August 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $10,454.95 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and no set-aside designation was applied. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location. This award is...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,130.48 by the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Glimepiride 4 mg tablets (100-count units). This is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-competitive, non-set-aside procurement. The award falls under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.96 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded on August 25, 2025, with an ultimate completion date of August 26, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Glimepiride 2 mg tablets in quantities of 100 units, with a ceiling value of $1,260.82 and an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3QSPDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,799.68 to AmerisourceBergen Drug Corp for Glimepiride 1 mg tablets in quantities of 100 units. The contract is a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Glimepiride is an oral medication used in the management of type 2 diabetes mellitus, and this delivery order is one of numerous pharmaceutical procurements executed under the company's larger contract vehicle with the DLA. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The IDC serves as the primary mechanism through which the DLA sources a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and medical devices across multiple therapeutic categories. The contract reflects the company's established capability to meet federal procurement requirements and support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems on a global basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/4/25 |